Tilray Announces Completion Of Series A Funding Round Led by Global Institutional Investors

C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe CANADA:  Tilray has announced the completion of its Series A funding round totaling C$60 million. The round was comprised of a group of leading global institutional investors. According to a company press release, Tilray will use Read the full article…

Tilray Exports Medical Cannabis Genetics To The European Union

PORTUGAL: Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal. The announcement is the first time a company has legally exported live cannabis genetics from North America Read the full article…

Tilray Exports Medical Cannabis Products To New Zealand or Nationwide Distribution

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid Read the full article…

Tilray Receives License to Produce Medical Cannabis In The European Union

Company Announces €20 Million Investment to Build EU Campus and Begin Operations this Year PORTUGAL: Tilray has announced plans today to invest up to €20 million in a European Union Campus after receiving licenses from the Government of Portugal to import cannabis genetics and to cultivate cannabis for medical purposes. “Tilray’s EU Campus is another strategic Read the full article…

Tilray Announces Second Facility To Meet Rapidly Growing Global Demand For Medical Cannabis

CANADA: Tilray Canada Ltd., a global leader in medical cannabis research and production, has announced that it will invest, through an affiliated entity, up to $30 million in a second cultivation and processing facility located in Enniskillen, Ontario. The two facilities will generate a combined production capacity of up to 51 metric tonnes per year, which will Read the full article…

Tilray Announces Support For Clinical Trial Examining Cannabis And Chronic Lung Disease

CANADA: Tilray, a global leader in medical cannabis research and production, today announced a partnership with the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, one of the world’s premier public academic and research institutions, to study the effects of vaporized cannabis on symptoms associated with chronic obstructive pulmonary disease (COPD). The Phase II trial will Read the full article…

Tilray Announces Medical Cannabis Export To Cyprus

CANADA:  Tilray, a global leader in medical cannabis research and production, today announced that Tilray cannabinoid products have arrived and are cleared for distribution in European Union member state Cyprus after the company received necessary approvals in Canada and Cyprus to export cannabinoid formulations for patients in Cyprus. “We are proud to be able to offer Read the full article…

Tilray Completes First Bulk Medical Cannabis Export To Australia Under New Regulations

CANADA: Tilray, a global leader in medical cannabis research and production, today announced it has completed its first import of medical cannabis products into Australia under the country’s new import regulations. The products were produced at Tilray’s federally licensed, GMP-certified facility in Canada and can be dispensed to any patient with a valid prescription. “We are Read the full article…

Tilray Becomes North America’s First GMP Certified Medical Cannabis Producer

CANADA: Tilray, a global leader in medical cannabis research and production, today announced that it has become the first medical cannabis producer in North America to be GMP certified in accordance with the European Medicines Agency’s (EMA) Good Manufacturing Practice (GMP) standards. As North America’s only GMP certified medical cannabis producer, Tilray is uniquely positioned to expand Read the full article…

Doctors Being Paid For Medical Marijuana Referrals, Company Says

CANADA:  A major producer of medical marijuana says doctors and specialized clinics are receiving kickbacks from some licensed pot producers in exchange for sending them patients, a practice the company calls unethical and a violation of professional medical standards. Greg Engel, CEO of Nanaimo, B.C.-based Tilray, said his company recently resigned from the Canadian Medical Read the full article…